Investing Ideas
/
Danish Pharmaceuticals & Biotech Potentially Undervalued Companies

Danish Pharmaceuticals & Biotech Potentially Undervalued Companies

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

Companies with a Value score of at least 3, ordered by Value score

5 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
HLUN B H. Lundbeck	DKK 41.16	-2.9%	27.5%	DKK 38.9b	DKK 50.14	PE15.2x	E8.8%	1.7%
GMAB Genmab	DKK 1,486.50	-3.2%	-29.5%	DKK 90.7b	DKK 2,340.18	PE20.1x	E23.5%	n/a
BAVA Bavarian Nordic	DKK 193.50	-0.3%	10.6%	DKK 15.2b	DKK 319.50	PE13.6x	E3.6%	n/a
HLUN A H. Lundbeck	DKK 32.85	-6.3%	15.1%	DKK 38.9b	DKK 40.37	PE15.1x	E8.8%	1.7%
NOVO B Novo Nordisk	DKK 769.90	-1.6%	12.8%	DKK 3.4t	DKK 944.92	PE36x	E14.3%	1.3%

Page 1 of 1